Acne vulgaris: False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma

Timothy M. Pawlik, Jeremy J. Erasmus, Mylene T. Truong, Homer Macapinlac, Merrick I. Ross, Jeffrey E. Gershenwald

Research output: Contribution to journalArticle

Abstract

Malignant melanoma was diagnosed in approximately 59,580 patients in the United States in 2005. Appropriate treatment of patients with this tumor depends on accurate staging at presentation. CT has been used in the evaluation of melanoma at high risk of metastasis (i.e., thick, ulcerated primary tumors [stage IIC] or stage III disease). Because the accuracy of CT in the detection of occult metastatic lesions is limited, whole-body 18F-FDG PET has emerged as a complementary imaging technique and is being used with increasing frequency in examinations of patients with advanced melanoma [1, 2]. Although integration of PET and CT findings increases diagnostic accuracy, use of this combination in the detection of distant metastatic lesions is associated with a high false-positive rate [3]. Awareness of potential diagnostic pitfalls is therefore needed to avoid misinterpretation of integrated PET/CT images that can lead to inaccurate staging. In particular, accurate identification of cutaneous and subcutaneous metastasis of melanoma is important because the lesions may represent new or additional regional or distant metastatic disease. Such findings may influence the overall treatment approach. We report the case of a patient with melanoma lymph node metastasis (American Joint Committee on Cancer stage III) who had 18F-FDG accumulation at the sites of acne vulgaris that might have been misinterpreted as evidence of multiple distant cutaneous or subcutaneous metastatic lesions, potentially altering the pre-PET surgical treatment plan of regional lymph node dissection.

Original languageEnglish (US)
Pages (from-to)251
Number of pages1
JournalAmerican Journal of Roentgenology
Volume187
Issue number1
DOIs
StatePublished - Jul 2006
Externally publishedYes

Fingerprint

Fluorodeoxyglucose F18
Acne Vulgaris
Melanoma
Neoplasm Metastasis
Neoplasms
Skin
Lymph Node Excision
Therapeutics
Lymph Nodes

Keywords

  • Acne vulgaris
  • Cancer
  • Melanoma
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Pawlik, T. M., Erasmus, J. J., Truong, M. T., Macapinlac, H., Ross, M. I., & Gershenwald, J. E. (2006). Acne vulgaris: False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. American Journal of Roentgenology, 187(1), 251. https://doi.org/10.2214/AJR.04.1986

Acne vulgaris : False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. / Pawlik, Timothy M.; Erasmus, Jeremy J.; Truong, Mylene T.; Macapinlac, Homer; Ross, Merrick I.; Gershenwald, Jeffrey E.

In: American Journal of Roentgenology, Vol. 187, No. 1, 07.2006, p. 251.

Research output: Contribution to journalArticle

Pawlik, TM, Erasmus, JJ, Truong, MT, Macapinlac, H, Ross, MI & Gershenwald, JE 2006, 'Acne vulgaris: False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma', American Journal of Roentgenology, vol. 187, no. 1, pp. 251. https://doi.org/10.2214/AJR.04.1986
Pawlik, Timothy M. ; Erasmus, Jeremy J. ; Truong, Mylene T. ; Macapinlac, Homer ; Ross, Merrick I. ; Gershenwald, Jeffrey E. / Acne vulgaris : False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. In: American Journal of Roentgenology. 2006 ; Vol. 187, No. 1. pp. 251.
@article{0647af28f48e4375ab7b50eda444c8c1,
title = "Acne vulgaris: False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma",
abstract = "Malignant melanoma was diagnosed in approximately 59,580 patients in the United States in 2005. Appropriate treatment of patients with this tumor depends on accurate staging at presentation. CT has been used in the evaluation of melanoma at high risk of metastasis (i.e., thick, ulcerated primary tumors [stage IIC] or stage III disease). Because the accuracy of CT in the detection of occult metastatic lesions is limited, whole-body 18F-FDG PET has emerged as a complementary imaging technique and is being used with increasing frequency in examinations of patients with advanced melanoma [1, 2]. Although integration of PET and CT findings increases diagnostic accuracy, use of this combination in the detection of distant metastatic lesions is associated with a high false-positive rate [3]. Awareness of potential diagnostic pitfalls is therefore needed to avoid misinterpretation of integrated PET/CT images that can lead to inaccurate staging. In particular, accurate identification of cutaneous and subcutaneous metastasis of melanoma is important because the lesions may represent new or additional regional or distant metastatic disease. Such findings may influence the overall treatment approach. We report the case of a patient with melanoma lymph node metastasis (American Joint Committee on Cancer stage III) who had 18F-FDG accumulation at the sites of acne vulgaris that might have been misinterpreted as evidence of multiple distant cutaneous or subcutaneous metastatic lesions, potentially altering the pre-PET surgical treatment plan of regional lymph node dissection.",
keywords = "Acne vulgaris, Cancer, Melanoma, PET",
author = "Pawlik, {Timothy M.} and Erasmus, {Jeremy J.} and Truong, {Mylene T.} and Homer Macapinlac and Ross, {Merrick I.} and Gershenwald, {Jeffrey E.}",
year = "2006",
month = "7",
doi = "10.2214/AJR.04.1986",
language = "English (US)",
volume = "187",
pages = "251",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "1",

}

TY - JOUR

T1 - Acne vulgaris

T2 - False-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma

AU - Pawlik, Timothy M.

AU - Erasmus, Jeremy J.

AU - Truong, Mylene T.

AU - Macapinlac, Homer

AU - Ross, Merrick I.

AU - Gershenwald, Jeffrey E.

PY - 2006/7

Y1 - 2006/7

N2 - Malignant melanoma was diagnosed in approximately 59,580 patients in the United States in 2005. Appropriate treatment of patients with this tumor depends on accurate staging at presentation. CT has been used in the evaluation of melanoma at high risk of metastasis (i.e., thick, ulcerated primary tumors [stage IIC] or stage III disease). Because the accuracy of CT in the detection of occult metastatic lesions is limited, whole-body 18F-FDG PET has emerged as a complementary imaging technique and is being used with increasing frequency in examinations of patients with advanced melanoma [1, 2]. Although integration of PET and CT findings increases diagnostic accuracy, use of this combination in the detection of distant metastatic lesions is associated with a high false-positive rate [3]. Awareness of potential diagnostic pitfalls is therefore needed to avoid misinterpretation of integrated PET/CT images that can lead to inaccurate staging. In particular, accurate identification of cutaneous and subcutaneous metastasis of melanoma is important because the lesions may represent new or additional regional or distant metastatic disease. Such findings may influence the overall treatment approach. We report the case of a patient with melanoma lymph node metastasis (American Joint Committee on Cancer stage III) who had 18F-FDG accumulation at the sites of acne vulgaris that might have been misinterpreted as evidence of multiple distant cutaneous or subcutaneous metastatic lesions, potentially altering the pre-PET surgical treatment plan of regional lymph node dissection.

AB - Malignant melanoma was diagnosed in approximately 59,580 patients in the United States in 2005. Appropriate treatment of patients with this tumor depends on accurate staging at presentation. CT has been used in the evaluation of melanoma at high risk of metastasis (i.e., thick, ulcerated primary tumors [stage IIC] or stage III disease). Because the accuracy of CT in the detection of occult metastatic lesions is limited, whole-body 18F-FDG PET has emerged as a complementary imaging technique and is being used with increasing frequency in examinations of patients with advanced melanoma [1, 2]. Although integration of PET and CT findings increases diagnostic accuracy, use of this combination in the detection of distant metastatic lesions is associated with a high false-positive rate [3]. Awareness of potential diagnostic pitfalls is therefore needed to avoid misinterpretation of integrated PET/CT images that can lead to inaccurate staging. In particular, accurate identification of cutaneous and subcutaneous metastasis of melanoma is important because the lesions may represent new or additional regional or distant metastatic disease. Such findings may influence the overall treatment approach. We report the case of a patient with melanoma lymph node metastasis (American Joint Committee on Cancer stage III) who had 18F-FDG accumulation at the sites of acne vulgaris that might have been misinterpreted as evidence of multiple distant cutaneous or subcutaneous metastatic lesions, potentially altering the pre-PET surgical treatment plan of regional lymph node dissection.

KW - Acne vulgaris

KW - Cancer

KW - Melanoma

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=33846210583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846210583&partnerID=8YFLogxK

U2 - 10.2214/AJR.04.1986

DO - 10.2214/AJR.04.1986

M3 - Article

C2 - 16794124

AN - SCOPUS:33846210583

VL - 187

SP - 251

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 1

ER -